Double-Digit Revenue Growth Driven by Strategic Initiatives Across Industrial and Advanced Solutions

Focused on Driving Margin Expansion

MARLBOROUGH, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial results for the third quarter ended September 30, 2026.

		Tre mesi chiusi al 30 settembre,											Nove mesi chiusi al 30 settembre,
(In milioni, esclusi i dati per azione e le percentuali)			2026				2025			Cambiamento				2026				2025			Cambiamento
Ricavi		$	287.5			$	250.8			15	%		$	831.6			$	729.3			14	%
Margine lordo			40.7	%			39.5	%						39.6	%			38.7	%
Utile operativo		$	20.8			$	7.9			NM			$	17.6			$	9.8			NM
Margine operativo			7.2	%			3.1	%						2.1	%			1.3	%
Utile netto		$	20.3			$	7.5			171	%		$	27.1			$	17.8			52	%
Utile per azione diluita		$	0.47			$	0.18			161	%		$	0.63			$	0.42			50	%
Indicatori non GAAP*
Margine lordo rettificato			41.0	%			39.8	%						39.9	%			39.2	%
EBITDA rettificato		$	51.5			$	37.0			39	%		$	135.2			$	101.2			34	%
Utile per azione diluito		$	0.61			$	0.35			74	%		$	1.49			$	0.96			55	%

*Il margine lordo rettificato, l'EBITDA rettificato e l'utile per azione diluito rettificato includono rettifiche non GAAP. Nel presente comunicato stampa sui risultati finanziari è riportata una riconciliazione tra i dati GAAP e quelli non GAAP.

NM - non significativo.

Management Comments
“We delivered our fourth consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance,” said Dr. Mark Gitin, Chief Executive Officer of IPG Photonics. “Our performance reflects the strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets. Strong demand for our differentiated welding and additive manufacturing solutions drove growth in Industrial Solutions while disciplined execution of our key strategic initiatives across defense and semiconductor markets led to strong growth in Advanced Solutions. Additionally, I anticipate that our acquisition of Lumibird Medical, which is expected to close in the fourth quarter, will further strengthen our reach, accelerate growth across medical markets, and increase revenue in Advanced Solutions.”

Dati di sintesi finanziari

	Tre mesi chiusi al 30 settembre,									Nove mesi chiusi al 30 settembre,
		2026			2025		Cambiamento				2026			2025		Cambiamento
Vendite per settore di applicazione
Soluzioni industriali	$	239,548		$	214,697		12	%		$	704,181		$	607,593		16	%
Soluzioni avanzate		47,952			36,095		33	%			127,396			121,713		5	%
Totale	$	287,500		$	250,792		15	%		$	831,577		$	729,306		14	%

Third quarter revenue of $288 million increased 15% year over year, driven by 12% growth in Industrial Solutions and 33% growth in Advanced Solutions. Changes in foreign exchange rates increased revenue by approximately 1%. Industrial Solutions sales, accounting for 83% of total revenue, were driven by strong performance in welding and additive manufacturing applications. Advanced Solutions sales improved, driven by higher sales in semiconductor and defense applications. Emerging growth products accounted for 52% of total revenue, down from 58% in the prior quarter due to product mix. By region, sales increased 14% in Asia and 33% in North America and decreased 1% in Europe on a year-over-year basis.

GAAP gross margin of 40.7% and adjusted gross margin of 41.0% increased year over year, driven by lower product costs and $5.0 million in net tariff refunds recorded in the period, partially offset by lower fixed cost absorption. Net income was $20 million, or $0.47 per diluted share, and adjusted EBITDA was $52 million and adjusted earnings per diluted share (EPS) was $0.61 in the third quarter. During the third quarter, IPG generated $46 million in cash flow from operations and spent $17 million on capital expenditures.

Prospettive aziendali e indicazioni finanziarie

“Our third quarter book-to-bill was approximately one as we continued to see improved industrial demand and executed on our strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers. As we move forward, we remain focused on driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio,” concluded Dr. Gitin.

For the fourth quarter of 2026, IPG expects revenue of $265 million to $295 million, adjusted gross margin between 37.0% and 40.0% and adjusted operating expenses of $91 million to $94 million. IPG anticipates delivering adjusted earnings per diluted share in the range of $0.30 to $0.60 and adjusted EBITDA in the range of $33 million to $50 million. The guidance assumes no contribution from the acquisition of Lumibird Medical.

As discussed in more detail in the "Safe Harbor" passage of this news release, actual results may differ from this guidance due to various factors including, but not limited to, trade policy changes and trade restrictions, product demand, order cancellations and delays, competition, tariffs and retaliatory tariffs, currency fluctuations and general economic conditions. The current uncertainty related to the trade environment and tariff policies increases the risks to the outlook that we have provided. This guidance is based upon current market conditions and expectations and is subject to the risks outlined in the Company's reports filed with the SEC and assumes exchange rates relative to the U.S. dollar of euro 0.88, Japanese yen 157 and Chinese yuan 6.74, respectively.

Informazioni finanziarie supplementari

Additional supplemental financial information is provided in the unaudited Financial Data Workbook and Third Quarter 2026 Earnings Call Presentation available on the investor relations section of the Company's website at investor.ipgphotonics.com.

Promemoria della teleconferenza

The Company will hold a conference call today, November 3, 2026 at 10:00 am ET. To access the call, please dial 877-407-6184 in the US or 201-389-0877 internationally. A live webcast of the call will also be available and archived on the investor relations section of the Company's website at investor.ipgphotonics.com.

Contatto

Eugene Fedotoff
Direttore senior, relazioni con gli investitori
IPG Photonics Corporation
508-597-4713
efedotoff@ipgphotonics.com

Informazioni su IPG Photonics Corporation

Innovation is at the heart of IPG Photonics. As a global leader in laser technology, we apply light to transform the world. From manufacturing to medical and beyond, our breakthrough laser solutions power our customers’ success and expand what's possible. Discover more at www.ipgphotonics.com.

Safe Harbor Statement
Information and statements provided by IPG and its employees, including statements in this press release, that relate to future plans, events or performance are forward-looking statements. These statements involve risks and uncertainties. Any statements in this press release that are not statements of historical fact are forward-looking statements, including those statements related to strength of our technology, disciplined execution, and continued progress in expanding our presence in attractive, higher-growth markets, the expected timing of the closing of our acquisition of Lumibird Medical and the expectation that the acquisition will increase revenue in Advanced Solutions and strengthen our reach and accelerate growth across medical markets, strategic growth initiatives, driving adoption for our differentiated laser and photonics solutions that deliver measurable value to customers, driving profitable growth through innovation, technology differentiation, and operational excellence across our portfolio, revenue, adjusted gross margin and adjusted operating expenses outlook, adjusted earnings per diluted share and adjusted EBITDA guidance, including the expected impact of tariffs, and the impact of the U.S. dollar on our guidance for the fourth quarter of 2026. Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated with the strength or weakness of business conditions in industries and geographic markets that IPG serves, particularly the effect of downturns in the markets IPG serves; uncertainties and adverse changes in the general economic conditions of markets; inability to manage risks associated with international customers and operations; changes in trade controls and tariff policies; IPG's ability to penetrate new applications for fiber lasers and increase market share; the rate of acceptance and penetration of IPG's products; foreign currency fluctuations; high levels of fixed costs from IPG's vertical integration; the appropriateness of IPG's manufacturing capacity for the level of demand; competitive factors, including declining average selling prices; the effect of acquisitions and investments; inventory write-downs; asset impairment charges; intellectual property infringement claims and litigation; interruption in supply of key components; manufacturing risks; government regulations and trade sanctions; and other risks identified in IPG's SEC filings. Readers are encouraged to refer to the risk factors described in IPG's Annual Report on Form 10-K (filed with the SEC for the fiscal year ended December 31, 2025), IPG's Quarterly Report on Form 10-Q (filed with the SEC for the quarter ended June 30, 2026), and other reports filed with the SEC, as applicable. Actual results, events and performance may differ materially. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date hereof. IPG undertakes no obligation to update the forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
		Tre mesi chiusi al 30 settembre,							Nove mesi chiusi al 30 settembre,
			2026				2025			2026			2025
		(In migliaia, esclusi i dati per azione)
Vendite nette		$	287,500			$	250,792		$	831,577		$	729,306
Costo del venduto			170,446				151,787			502,500			446,916
Utile lordo			117,054				99,005			329,077			282,390
Spese operative:
Vendite e marketing			23,934				23,771			72,286			73,753
Ricerca e sviluppo			31,335				30,358			95,648			88,631
Generale e amministrativo			37,502				35,092			110,139			102,782
Risoluzione delle controversie			-				-			13,334			-
Oneri per svalutazioni			231				-			17,805			-
Oneri di ristrutturazione			-				425			-			425
Perdita su cambi			3,275				1,504			2,293			7,013
Totale spese operative			96,277				91,150			311,505			272,604
Utile operativo			20,777				7,855			17,572			9,786
Altri proventi, netti:
Interessi attivi, netti			7,688				7,283			21,720			22,728
Other (expense) income, net			(50	)			516			2,683			2,026
Totale altri proventi			7,638				7,799			24,403			24,754
Utile al lordo delle imposte sul reddito			28,415				15,654			41,975			34,540
Accantonamento per imposte sul reddito			8,142				8,191			14,876			16,714
Utile netto		$	20,273			$	7,463		$	27,099		$	17,826
Utile netto per azione ordinaria:
Base		$	0.48			$	0.18		$	0.64		$	0.42
Diluito		$	0.47			$	0.18		$	0.63		$	0.42
Media ponderata delle azioni ordinarie in circolazione:
Base			42,531				42,199			42,416			42,427
Diluito			42,840				42,556			42,904			42,659

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
		30 settembre,				31 dicembre,
			2026				2025
		(In thousands, except share data)
ATTIVITÀ
Attività correnti:
Liquidità ed equivalenti di cassa		$	710,688			$	403,790
Investimenti a breve termine			215,304				435,538
Crediti, netti			191,150				181,734
Inventari			337,890				313,416
Imposte sul reddito anticipate			33,145				43,196
Risconti attivi e altre attività correnti			54,460				45,766
Totale attività correnti			1,542,637				1,423,440
Investimenti a lungo termine			-				76,533
Imposte sul reddito differite, nette			122,235				123,889
Avviamento			70,281				71,735
Attività immateriali, nette			42,777				49,933
Immobili, impianti e attrezzature, netti			648,326				637,516
Altre attività			45,787				41,234
Totale attività		$	2,472,043			$	2,424,280
PASSIVITÀ E PATRIMONIO NETTO
Passività correnti:
Debiti		$	48,782			$	39,288
Ratei passivi e altre passività correnti			204,874				184,849
Imposte sul reddito da pagare			3,858				9,900
Totale passività correnti			257,514				234,037
Altre passività a lungo termine e imposte differite sul reddito			59,581				62,113
Totale passività			317,095				296,150
Impegni e imprevisti
Patrimonio netto:
Common stock, $0.0001 par value, 175,000,000 shares authorized; 57,380,668 and 42,508,140 shares issued and outstanding, respectively, at September 30, 2026; 56,964,939 and 42,127,067 shares issued and outstanding, respectively, at December 31, 2025.			6				6
Treasury stock, at cost, 14,872,528 and 14,837,872 shares held at September 30, 2026 and December 31, 2025, respectively.			(1,558,277	)			(1,555,629	)
Riserva di capitale versato			1,097,673				1,077,172
Utili a nuovo			2,672,063				2,644,964
Altre perdite complessive accumulate			(56,517	)			(38,383	)
Patrimonio netto complessivo			2,154,948				2,128,130
Totale passività e patrimonio netto		$	2,472,043			$	2,424,280

 

IPG PHOTONICS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
		Nove mesi chiusi al 30 settembre,
			2026				2025
		(in migliaia)
Flussi di cassa da attività operative:
Utile netto		$	27,099			$	17,826
Rettifiche per riconciliare l'utile netto con la liquidità netta fornita dalle attività operative:
Ammortamenti e svalutazioni			47,377				46,799
Oneri per svalutazioni			17,805				-
Accantonamenti per inventario, garanzia e crediti inesigibili			33,594				31,766
Altro			25,081				21,119
Changes in assets and liabilities that provided (used) cash:
Crediti e debiti			1,535				18,787
Inventari			(60,189	)			(52,005	)
Altro			(13,771	)			(37,757	)
Liquidità netta generata da attività operative			78,531				46,535
Flussi di cassa da attività di investimento:
Acquisti e depositi di immobili, impianti e macchinari			(54,437	)			(60,907	)
Ricavi dalla vendita di immobili, impianti e macchinari			2,204				605
Acquisti di titoli			(360,732	)			(866,402	)
Purchases of equity investment			(8,000	)			-
Proventi derivanti dalla scadenza di investimenti			663,124				633,731
Acconto ricevuto dall'acquirente per le attività destinate alla vendita			2,000				-
Altro			111				69
Liquidità netta generata (utilizzata) da attività di investimento			244,270				(292,904	)
Flussi di cassa da attività di finanziamento:
Payments for taxes related to net share settlement of equity awards less proceeds from issuance of common stock under employee stock option and purchase plans			(11,053	)			(4,316	)
Acquisto di azioni proprie al costo, al netto dell'imposta sui consumi			(2,648	)			(46,603	)
Liquidità netta utilizzata nelle attività di finanziamento			(13,701	)			(50,919	)
Effetto delle variazioni dei tassi di cambio sulla liquidità, sugli equivalenti di liquidità e sulle disponibilità destinate alla vendita			(1,727	)			23,274
Net increase (decrease) in cash, cash equivalents and cash held for sale			307,373				(274,014	)
Disponibilità liquide ed equivalenti - Inizio del periodo			403,790				620,040
Disponibilità liquide, mezzi equivalenti e attività destinate alla vendita — Fine periodo		$	711,163			$	346,026
Informazioni supplementari sui flussi di cassa:
Contanti pagati per interessi		$	54			$	136
Contanti versati a titolo di imposte sul reddito, al netto dei rimborsi		$	9,273			$	44,258
IPG PHOTONICS CORPORATION PROSPETTO SUPPLEMENTARE DELLE MISURE FINANZIARIE NON-GAAP (NON SOTTOPOSTO A REVISIONE)

Utilizzo di informazioni finanziarie rettificate non-GAAP

We refer to certain financial measures that are not recognized under United States generally accepted accounting principles (“GAAP”) and are provided as supplemental information to enhance understanding of the Company’s financial performance. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measure presented by the Company. The following information provides the definition of adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted net earnings per share (EPS), and adjusted tax rate as presented, which are financial measures that are not calculated or presented in accordance with GAAP, and reconciliation to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided adjusted gross profit, adjusted gross margin, adjusted operating expense and resultant adjusted operating income, EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and an adjusted tax rate as supplemental information and in addition to the financial measures presented by the Company that are calculated and presented in accordance with GAAP.

We define adjusted gross profit as reported gross profit, adjusted for non-recurring, infrequent, or unusual charges, including acquisition and integration charges and amortization of acquisition-related intangibles.

Definiamo il margine lordo rettificato come l'utile lordo rettificato diviso per il fatturato totale.

We define adjusted operating expense and resultant adjusted operating income as reported operating expenses and resultant operating income, adjusted for non-recurring, infrequent, or unusual charges, including impairment charges, settlement and fees of litigation matters, restructuring charges, acquisition and integration charges, amortization of acquisition-related intangibles, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

Definiamo l'EBITDA come l'utile netto più gli interessi passivi (o attivi), le imposte sul reddito, gli ammortamenti e le svalutazioni.

We define adjusted EBITDA as EBITDA adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including stock-based compensation, restructuring charges, impairment charges, settlement and fees of litigation matters, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture.

We define adjusted net income as reported net income, adjusted for non-recurring, infrequent, or unusual charges, and other adjustments that the Company believes appropriate, including impairment charges, settlement and fees of litigation matters, restructuring charges, amortization of acquisition-related intangibles, acquisition and integration charges, foreign exchange gains/losses and gain/loss on disposal of assets/divestiture, certain discrete tax items and non-GAAP income tax reconciling adjustments.

Definiamo l'utile per azione rettificato come l'utile netto rettificato diviso per il numero medio ponderato di azioni diluite in circolazione.

Definiamo l'aliquota fiscale rettificata come l'aliquota fiscale GAAP, rettificata per le voci fiscali una tantum e per l'impatto netto delle rettifiche non GAAP.

Il management ritiene che tali indicatori finanziari non GAAP offrano ulteriori strumenti per valutare l'andamento operativo su base comparativa. Nello specifico, tali indicatori finanziari non GAAP forniscono al management ulteriori strumenti per comprendere e valutare i risultati operativi e le tendenze dell'attività corrente, eliminando alcune spese non monetarie e altre voci che, a suo avviso, potrebbero altrimenti rendere più difficile il confronto dell'attività corrente con i periodi precedenti, oscurare le tendenze delle operazioni correnti o ridurre la capacità del management di formulare previsioni utili.

In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors. However, these non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies. Management may, however, utilize other measures to illustrate performance in the future. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP measures has been provided below. These non-GAAP measures exclude (i) amortization of acquisition-related intangibles, (ii) restructuring charges, (iii) acquisition and integration costs, (iv) impairment charges, (v) foreign exchange gains/losses, (vi) interest income, (vii) benefit (provision) from income taxes, (viii) depreciation, (ix) amortization, (x) stock-based compensation, (xi) gain/loss on disposal of assets/divestiture, (xii) settlement and fees of litigation matters, (xiii) certain discrete tax items, and (xiv) non-GAAP income tax reconciling adjustments.

Non abbiamo fornito una riconciliazione quantitativa dell'utile per azione diluito rettificato non GAAP e dell'EBITDA rettificato, entrambi di natura previsionale, con le misure finanziarie GAAP più direttamente comparabili, poiché non siamo in grado di stimare con ragionevole certezza la tempistica definitiva o l'ammontare di alcune voci significative senza uno sforzo eccessivo. Ciò è dovuto alla difficoltà intrinseca di prevedere la tempistica e/o l'ammontare di varie voci che potrebbero influire sull'utile rettificato per azione diluita e sull'EBITDA rettificato. Ciò include voci che non si sono ancora verificate, che esulano dal controllo della Società, che non possono essere ragionevolmente previste e/o per le quali non vi sarebbe alcuna rettifica o differenza significativa. Per gli stessi motivi, la Società non è in grado di valutare la probabile rilevanza delle informazioni non disponibili.

Our non-GAAP tax provision for the fiscal third quarter of 2026 is 23%. The difference between our GAAP income tax provision and our non-GAAP income tax provision is presented as non-GAAP income tax reconciling adjustments.

IPG PHOTONICS CORPORATION SUPPLEMENTAL SCHEDULE OF NON-GAAP MEASURES (UNAUDITED)
Riconciliazione dell'utile lordo con l'utile lordo rettificato e il margine lordo rettificato
		Tre mesi chiusi al 30 settembre,								Nove mesi chiusi al 30 settembre,
			2026				2025				2026				2025
		(in migliaia, eccetto le percentuali)
Utile lordo		$	117,054			$	99,005			$	329,077			$	282,390
Margine lordo			40.7	%			39.5	%			39.6	%			38.7	%
Ammortamento delle immobilizzazioni immateriali relative all'acquisizione			720				851				2,360				2,928
Costi di acquisizione e integrazione			-				-				-				482
Utile lordo rettificato		$	117,774			$	99,856			$	331,437			$	285,800
Margine lordo rettificato			41.0	%			39.8	%			39.9	%			39.2	%

Reconciliation of Operating Expenses to Adjusted Operating Expenses

		Tre mesi chiusi al 30 settembre,						Nove mesi chiusi al 30 settembre,
			2026			2025			2026			2025
		(in migliaia)
Operating expenses		$	96,277		$	91,150		$	311,505		$	272,604
Less:
Ammortamento delle immobilizzazioni immateriali relative all'acquisizione			1,231			1,551			3,701			4,570
Costi di acquisizione e integrazione			151			246			987			1,823
Oneri per svalutazioni			231			-			17,805			-
Oneri di ristrutturazione			149			425			500			425
Transazioni e spese relative a contenziosi			-			-			14,435			-
Perdita su cambi			3,275			1,504			2,293			7,013
Adjusted operating expenses		$	91,240		$	87,424		$	271,784		$	258,773

Reconciliation of Operating Income to Adjusted Operating Income

		Tre mesi chiusi al 30 settembre,						Nove mesi chiusi al 30 settembre,
			2026			2025			2026			2025
		(in migliaia)
Utile operativo		$	20,777		$	7,855		$	17,572		$	9,786
Ammortamento delle immobilizzazioni immateriali relative all'acquisizione			1,951			2,402			6,061			7,498
Costi di acquisizione e integrazione			151			246			987			2,305
Oneri per svalutazioni			231			-			17,805			-
Oneri di ristrutturazione			149			425			500			425
Transazioni e spese relative a contenziosi			-			-			14,435			-
Perdita su cambi			3,275			1,504			2,293			7,013
Risultato operativo rettificato		$	26,534		$	12,432		$	59,653		$	27,027

Riconciliazione dell'utile netto con l'EBITDA rettificato

		Tre mesi chiusi al 30 settembre,								Nove mesi chiusi al 30 settembre,
			2026				2025				2026				2025
		(in migliaia)
Utile netto		$	20,273			$	7,463			$	27,099			$	17,826
Interessi attivi, netti			(7,688	)			(7,283	)			(21,720	)			(22,728	)
Accantonamento per imposte sul reddito			8,142				8,191				14,876				16,714
Ammortamento			12,986				12,392				38,447				36,120
Ammortamento			2,976				3,240				8,930				10,679
EBITDA		$	36,689			$	24,003			$	67,632			$	58,611
Oneri per svalutazioni			231				-				17,805				-
Retribuzioni basate su azioni			11,022				10,780				31,597				32,834
Oneri di ristrutturazione			149				425				500				425
Costi di acquisizione e integrazione			151				246				987				2,305
Transazioni e spese relative a contenziosi			-				-				14,435				-
Perdita su cambi			3,275				1,504				2,293				7,013
EBITDA rettificato		$	51,517			$	36,958			$	135,249			$	101,188

Riconciliazione tra l'utile netto GAAP e quello non GAAP, e tra l'utile netto per azione GAAP e quello non GAAP, diluito

		Tre mesi chiusi al 30 settembre,								Nove mesi chiusi al 30 settembre,
			2026				2025				2026				2025
		(in migliaia, eccetto i dati per azione)
Utile netto		$	20,273			$	7,463			$	27,099			$	17,826
Oneri per svalutazioni			231				-				17,805				-
Ammortamento delle immobilizzazioni immateriali relative all'acquisizione			1,951				2,402				6,061				7,498
Oneri di ristrutturazione			149				425				500				425
Costi di acquisizione e integrazione			151				246				987				2,305
Transazioni e spese relative a contenziosi			-				-				14,435				-
Perdita su cambi			3,275				1,504				2,293				7,013
Alcune voci fiscali specifiche			949				3,414				84				8,303
Impatto fiscale delle rettifiche non GAAP			(711	)			(613	)			(5,337	)			(2,471	)
Utile netto rettificato		$	26,268			$	14,841			$	63,927			$	40,899
Utile netto rettificato per azione diluita		$	0.61			$	0.35			$	1.49			$	0.96
Media ponderata delle azioni diluite in circolazione			42,840				42,556				42,904				42,659

Riconciliazione tra il tasso d'imposta effettivo GAAP e quello non GAAP

		Tre mesi chiusi al 30 settembre,								Nove mesi chiusi al 30 settembre,
		2026				2025				2026				2025
Aliquota fiscale		29		%		52		%		35		%		48		%
Voci fiscali discrete		(3	)	%		(22	)	%		-		%		(24	)	%
Impatto netto delle rettifiche non GAAP		(3	)	%		(3	)	%		(11	)	%		(3	)	%
Aliquota fiscale rettificata		23		%		27		%		24		%		21		%

 

 

Fonte: IPG Photonics Corporation